Egon Zehnder
Search
Select region
Close filter

Henrik Aagaard

Contact Details

+45 33 11 13 53

Henrik Aagaard, based in Copenhagen, serves Scandinavian, European, and international clients in life sciences including pharma, biopharma, biotech, and medtech as well as industrial companies. He is experienced in senior level assignments including CEO succession, board succession, and board effectiveness consulting, and is frequently engaged in executive search for R&D leadership, supply chain experts, senior technical operations executives, and chief marketing officers. Henrik also provides leadership development and executive coaching.

Prior to joining Egon Zehnder, Henrik was President and CEO of American Pharmed Labs, a venture capital-backed medtech startup in the U.S. Previously, he was President of Novo Nordisk of North America, based in New York and responsible for Novo Nordisk corporate functions in North America. Earlier, Henrik was a Consultant with Matcon (part of the COWI Group), a Researcher at Business Weekly (Børsens Nyhedsmagasin), and an Associate Professor in Literature at University of Copenhagen.

Henrik earned an MA in literature and history from the University of Copenhagen and a Master of International Affairs (MIA) from Columbia University School of International Affairs.

He has served on the steering committee of Biotech Builders, a Danish life sciences network organization.

Get in touch
Send Henrik a Message
Browse all
Thought Leadership

Related Experts Around the Globe

Elaine Yew

Elaine Yew

Singapore

Elaine Yew is a Senior Partner in Egon Zehnder and Global Co-Head of our Leadership Advisory Practice. She serves private and public companies on… Read more

Lydia Guo

Lydia Guo

Beijing

Lydia Guo, is the co-practice leader of Egon Zehnder Health in Asia-Pacific and acts as a trusted advisor in executive search, leadership assessment… Read more

Eduard Knezevic

Eduard Knezevic

Zurich

Eduard Knezevic, Partner in the Zürich office, leads Egon Zehnder’s Industrial Practice in Switzerland and is part of the firm’s CEO Practice. Read more

Changing language

Close icon

You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.

Continue to the website

Back to top